Pharma & Biotech

After a punishing year that saw its value cut in half, Redcare Pharmacy shares are attracting renewed attention following a...

BioNxt Solutions has achieved a significant milestone in its commercial strategy. The biotechnology firm has been granted exclusive rights to...

The biotechnology firm aTyr Pharma is confronting a severe crisis after its pivotal Phase 3 clinical trial ended in failure....

The formal dissolution of one of biotech's most prominent partnerships has rattled investors, with Pfizer's complete exit from its BioNTech...

PDS Biotechnology Corporation's stock is experiencing significant downward momentum amid intense volatility, even as the company reports encouraging clinical trial...

Co-Diagnostics shares are experiencing dramatic price swings alongside a persistent downward trend. The stock plummeted more than 12% over a...

NuCana plc finds itself navigating turbulent waters as promising clinical developments clash with concerning technical indicators. The biopharmaceutical company's latest...

DexCom finds itself at a pivotal moment as conflicting developments create uncertainty for investors. The continuous glucose monitoring leader faces...

Cellectar Biosciences finds itself navigating turbulent market conditions as its shares experience significant volatility. The biopharmaceutical company faces a complex...

Investors in Anavex Life Sciences are bracing for what could prove to be a defining moment for the biopharmaceutical company....